Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.
Overview & Synopsis
Open access biomedical research article published in Antimicrob Agents Chemother.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial. |
|---|---|
| Author / Organization | Guo Y, Li Y, Zhao P, Bi J, Gou C, Chuai Z, Yu S, Zhang R, Du J, Ou Y, Xu R, Guo N, Wang F-S, Li Y |
| Subject & Discipline | Antimicrob Agents Chemother |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-68599 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |